Lou L[au] - Search Results

Year	Number of Results
1984	1
1986	3
1987	2
1989	4
1994	2
1995	9
1996	6
1997	4
1998	4
1999	9
2000	5
2001	4
2002	13
2003	10
2004	5
2005	10
2006	25
2007	21
2008	24
2009	22
2010	25
2011	31
2012	34
2013	37
2014	43
2015	45
2016	47
2017	62
2018	59
2019	68
2020	93
2021	91
2022	55

1

Targeting liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein promotes innate antiviral immunity by elevating MAVS activity.

Wang S, Dai T, Qin Z, Pan T, Chu F, Lou L, Zhang L, Yang B, Huang H, Lu H, Zhou F. Wang S, et al. Among authors: lou l. Nat Cell Biol. 2021 Jul;23(7):718-732. doi: 10.1038/s41556-021-00710-0. Epub 2021 Jul 8. Nat Cell Biol. 2021. PMID: 34239064

2

(2S,3R)-3-(2-Bromo-phen-yl)-2-nitro-2,3,6,7-tetra-hydro-1-benzo-furan-4(5H)-one.

Wang Y, Lou L, Dong K, Xu D. Wang Y, et al. Among authors: lou l. Acta Crystallogr Sect E Struct Rep Online. 2013 Jul 3;69(Pt 8):o1197. doi: 10.1107/S1600536813017698. eCollection 2013. Acta Crystallogr Sect E Struct Rep Online. 2013. PMID: 24109296 Free PMC article.

3

Retraction Notice to: Kcnq1ot1/miR-381-3p/ETS2 Axis Regulates Inflammation in Mouse Models of Acute Respiratory Distress Syndrome.

Jiang X, Yu M, Zhu T, Lou L, Chen X, Li Q, Wei D, Sun R. Jiang X, et al. Among authors: lou l. Mol Ther Nucleic Acids. 2022 Jun 14;28:588. doi: 10.1016/j.omtn.2022.05.011. Epub 2022 May 10. Mol Ther Nucleic Acids. 2022. PMID: 35572952 Free PMC article.

4

Polyphenols as alternative treatments of COVID-19.

Wu Y, Pegan SD, Crich D, Desrochers E, Starling EB, Hansen MC, Booth C, Nicole Mullininx L, Lou L, Chang KY, Xie ZR. Wu Y, et al. Among authors: lou l. Comput Struct Biotechnol J. 2021;19:5371-5380. doi: 10.1016/j.csbj.2021.09.022. Epub 2021 Sep 20. Comput Struct Biotechnol J. 2021. PMID: 34567475 Free PMC article.

5

Targeting mutated GTPase KRAS in tumor therapies.

Fan G, Lou L, Song Z, Zhang X, Xiong XF. Fan G, et al. Among authors: lou l. Eur J Med Chem. 2021 Dec 15;226:113816. doi: 10.1016/j.ejmech.2021.113816. Epub 2021 Sep 4. Eur J Med Chem. 2021. PMID: 34520956 Review.

6

Isochoric supercooling cryomicroscopy.

Zhao Y, Lou L, Lyu C, Powell-Palm MJ, Rubinsky B. Zhao Y, et al. Among authors: lou l. Cryobiology. 2022 Feb 18:S0011-2240(22)00018-9. doi: 10.1016/j.cryobiol.2022.02.002. Online ahead of print. Cryobiology. 2022. PMID: 35189096

7

Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.

Zhang C, Jin DD, Wang XY, Lou L, Yang J. Zhang C, et al. Among authors: lou l. J Cardiovasc Pharmacol. 2021 Feb 1;77(2):142-152. doi: 10.1097/FJC.0000000000000952. J Cardiovasc Pharmacol. 2021. PMID: 33538531 Review.

8

Selected Thoughts on Hydrophobicity in Drug Design.

Lou LL, Martin JC. Lou LL, et al. Molecules. 2021 Feb 7;26(4):875. doi: 10.3390/molecules26040875. Molecules. 2021. PMID: 33562230 Free PMC article.

9

Letter: the need to reconsider the liver-specific benefit of carvedilol.

He L, Lou L. He L, et al. Among authors: lou l. Aliment Pharmacol Ther. 2021 Aug;54(3):348. doi: 10.1111/apt.16383. Aliment Pharmacol Ther. 2021. PMID: 34236095 No abstract available.

10

Perspectives Regarding the Role of Biochanin A in Humans.

Yu C, Zhang P, Lou L, Wang Y. Yu C, et al. Among authors: lou l. Front Pharmacol. 2019 Jul 12;10:793. doi: 10.3389/fphar.2019.00793. eCollection 2019. Front Pharmacol. 2019. PMID: 31354500 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results